Introduction to Jun 19 2026 This Week In Cardiology
If you are looking for information about Jun 19 2026 This Week In Cardiology, you have come to the right place. Listener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, ...
Jun 19 2026 This Week In Cardiology Comprehensive Overview
Listener feedback, transcatheter tricuspid valve replacement, a new metabolic disease called CKM, the ARISE-FLUIDS Trial, the ... Listener feedback on valvular heart disease, statins and frailty, left atrial posterior wall ablation fails again, interpreting medical ... A life-long treatment for high LDL, a VESALIUS subanalysis, tirzepatide beats semaglutide again, arrhythmia burden in
Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on lipid ...
Summary & Highlights for Jun 19 2026 This Week In Cardiology
- Listener feedback, the huge CLOSURE-AF trial of LAAC vs best medical therapy, previews of CHAMPION AF, and the ...
- PCSK9 inhibitors in high-risk diabetes without ASCVD, the CAAN-AF trial, conduction system pacing vs biventricular pacing, PFA ...
- John Mandrola offers an ACC recap of 5 big trials—Hi-PEITHO, PROTAVI, ORBITA-CTO, CHIPS-BCIS3 and CHAMPION AF This ...
- Time to quadruple therapy, the disappointing AVANT GUARD trial, PFA risks, the TREAT-PVC trial, and NSTEMI care in the frail ...
- Welcome to This
We hope this detailed breakdown of Jun 19 2026 This Week In Cardiology was helpful.
